Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of valemetostat tosylate in relapsed or refractory adult T-cell leukemia/lymphoma
jRCT2080224880Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of valemetostat in adult T-cell leukemia-lymphoma (ATLL), sponsored by Daiichi Sankyo Co., Ltd. Started Sep 2019; status: completed.
02
Drugs
valemetostat
03
Conditions
adult T-cell leukemia-lymphoma (ATLL)
Beyond the preview
Go deeper on jRCT2080224880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224880.